These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33350096)

  • 1. SARS-CoV-2 effects on the renin-angiotensin-aldosterone system, therapeutic implications.
    Ye Q; Lai EY; Luft FC; Persson PB; Mao J
    Acta Physiol (Oxf); 2021 Apr; 231(4):e13608. PubMed ID: 33350096
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin-aldosterone system inhibitor dilemma in COVID-19: balancing cardiovascular benefits and viral risks.
    Okumura T; Murohara T
    Hypertens Res; 2024 Sep; 47(9):2598-2600. PubMed ID: 38951682
    [No Abstract]   [Full Text] [Related]  

  • 3. The controversy of using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in COVID-19 patients.
    Harky A; Chor CYT; Nixon H; Jeilani M
    J Renin Angiotensin Aldosterone Syst; 2021; 22(1):1470320320987118. PubMed ID: 33412991
    [No Abstract]   [Full Text] [Related]  

  • 4. The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.
    Liao WH; Yang GG; Henneberg M
    Swiss Med Wkly; 2020 Nov; 150():w20444. PubMed ID: 33306813
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19, hypertension, and renin-angiotensin-aldosterone system inhibitors: Much ado about nothing or real problem to be solved?
    Tadic M; Cuspidi C
    J Clin Hypertens (Greenwich); 2020 Nov; 22(11):1984-1986. PubMed ID: 32951351
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular disease and the impact of COVID-19.
    Yoganathan A; Sajjad MS; Harky A
    J Card Surg; 2020 Aug; 35(8):2113. PubMed ID: 32542799
    [No Abstract]   [Full Text] [Related]  

  • 7. What solid organ transplant healthcare providers should know about renin-angiotensin-aldosterone system inhibitors and COVID-19.
    Wong SY; Brubaker AL; Wang AX; Taiwo AA; Melcher ML
    Clin Transplant; 2020 Jul; 34(7):e13991. PubMed ID: 32446267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial.
    Mancia G
    Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-Angiotensin-Aldosterone System Inhibitors and Outcome in Patients With SARS-CoV-2 Pneumonia: A Case Series Study.
    Conversano A; Melillo F; Napolano A; Fominskiy E; Spessot M; Ciceri F; Agricola E
    Hypertension; 2020 Aug; 76(2):e10-e12. PubMed ID: 32383626
    [No Abstract]   [Full Text] [Related]  

  • 10. A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19.
    Usman MS; Siddiqi TJ; Khan MS; Ahmed A; Ali SS; Michos ED; Hall ME; Krasuski RA; Greene SJ; Butler J; Alkhouli M
    Am J Cardiol; 2020 Sep; 130():159-161. PubMed ID: 32624189
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for Therapy.
    Sansoè G; Aragno M; Wong F
    Hepatology; 2021 Aug; 74(2):1074-1080. PubMed ID: 33524188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-Angiotensin System Modulation in Adults With COVID-19-Reply.
    Self WH; DeClercq J; Orr M;
    JAMA; 2023 Aug; 330(7):664-665. PubMed ID: 37581675
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study.
    Bajaj RR; Wald R; Hackam DG; Gomes T; Perl J; Juurlink DN; Manno M; Garg AX; Kitchlu A; Mamdani MM; Yan AT
    Arch Intern Med; 2012 Apr; 172(7):591-3. PubMed ID: 22493468
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19: The heart of the issue.
    Woodward B; Kermali M
    J Card Surg; 2020 Aug; 35(8):2112. PubMed ID: 32542802
    [No Abstract]   [Full Text] [Related]  

  • 15. Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.
    Vaduganathan M; Vardeny O; Michel T; McMurray JJV; Pfeffer MA; Solomon SD
    N Engl J Med; 2020 Apr; 382(17):1653-1659. PubMed ID: 32227760
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 and inhibitors of the renin-angiotensin-aldosterone system.
    Hussain M; Jabeen Q; Ahmad FU; Kashif-Ur-Rehman ; Fatima M; Shaukat S; Majeed A; Barkat MQ; Wu X
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):815-816. PubMed ID: 33198546
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis.
    Guo X; Zhu Y; Hong Y
    Hypertension; 2020 Aug; 76(2):e13-e14. PubMed ID: 32458694
    [No Abstract]   [Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 as a versatile player in the management of coronavirus disease 2019.
    Amano T
    J Diabetes Investig; 2020 Sep; 11(5):1120-1122. PubMed ID: 32657484
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore.
    Saavedra JM
    Physiology (Bethesda); 2021 May; 36(3):160-173. PubMed ID: 33904788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.